Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval symbols : Bsx save search
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
Published: 2024-03-14 (Crawled : 11:00) - biospace.com/
BSX | $68.99 1.43% 0.19% 9.1M
|
Health Technology
|
| O: -0.15%
H: 1.47%
C: 1.4%
AXNX | $66.54 -0.45% -0.45% 1.1M
|
Health Technology
|
| O: -0.06%
H: 0.35%
C: 0.07%
axonics approval system
Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon
Published: 2024-03-01 (Crawled : 15:30) - biospace.com/
BSX | $68.99 1.43% 0.19% 9.1M
|
Health Technology
|
| O: 0.21%
H: 1.58%
C: 1.18%
fda approval
Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation System
Published: 2024-01-31 (Crawled : 22:00) - biospace.com/
BSX | $68.99 1.43% 0.19% 9.1M
|
Health Technology
|
| O: 4.2%
H: 0.77%
C: -1.16%
fda approval system
Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device
Published: 2023-09-06 (Crawled : 22:00) - biospace.com/
BSX | $68.99 1.43% 0.19% 9.1M
|
Health Technology
|
| O: -0.34%
H: 2.03%
C: 1.39%
fda device approval
Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX™ LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option
Published: 2022-09-06 (Crawled : 12:00) - biospace.com/
BSX | $68.99 1.43% 0.19% 9.1M
|
Health Technology
|
| O: 0.47%
H: 0.05%
C: -0.74%
fda device approval therapy
North America Disposable Endoscopes Market Report 2022-2030: Increasing Regulatory Approval & Manufacturer Innovation to Create Future Opportunities
Published: 2022-07-28 (Crawled : 12:00) - prnewswire.com
BSX | $68.99 1.43% 0.19% 9.1M
|
Health Technology
|
| O: -0.12%
H: 2.89%
C: 2.24%
america report approval innovation market
Boston Scientific Receives FDA Approval for TheraSphere™ Y-90 Glass Microspheres
Published: 2021-03-18 (Crawled : 12:00) - biospace.com/
BSX | $68.99 1.43% 0.19% 9.1M
|
Health Technology
|
| O: -0.08%
H: 0.31%
C: -1.7%
glass fda fda approval approval
Boston Scientific Receives FDA Approval For The Vercise Genus™ Deep Brain Stimulation System
Published: 2021-01-22 (Crawled : 13:00) - biospace.com/
BSX | $68.99 1.43% 0.19% 9.1M
|
Health Technology
|
| O: 0.03%
H: 0.17%
C: -1.33%
fda approval fda approval train
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.